Research
Excludes commercial-in-confidence projects.
Characterising an RNA splicing pathway driving prostate cancer metastasis and therapy resistance, NHMRC - Project Grant, 01/01/2019 - 31/12/2022
Discovering how microRNAs and circRNAs control cancer metastasis, NHMRC - Research Fellowship, 01/01/2017 - 31/12/2021
Use of a new molecule (miR-342) to discover important pathways to treat advanced breast cancer, NBCF - Investigator Initiated Research Scheme, 01/01/2018 - 01/07/2021
Develop efficient data mining methods for evidence based decision making, ARC - Discovery Projects, 29/06/2017 - 28/06/2021
Characterising novel alternative splicing networks that promote tumour cell plasticity, NHMRC - Project Grant, 01/01/2017 - 31/12/2019
Using miR-200 to find new therapeutic targets for neuroblastoma, NHMRC - Project Grant, 01/01/2017 - 31/12/2019
Functions of circular RNAs, NHMRC - Project Grant, 01/01/2017 - 31/12/2019
Cancer Discovery Accelerator, Australian Cancer Research Foundation, 01/06/2016 - 31/07/2018
Targeting microRNA-driven mesenchymal to epithelial transition to suppress prostate cancer metastasis, NHMRC - Project Grant, 01/01/2015 - 31/12/2017
Role of the microRNA target Quaking in alternative splicing during EMT and cancer progression, NHMRC - Project Grant, 01/01/2014 - 31/12/2017
Formation and function of circular RNAs in human cells, NHMRC - Project Grant, 01/01/2015 - 31/12/2017
Do circular RNAs affect breast cancer progression?, National Breast Cancer Foundation - Innovator Grant, 01/01/2016 - 31/12/2017
Cancer Discovery Accelerator, Cancer Council SA - Beat Cancer, 08/06/2016 - 08/06/2017
Research
Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included. To see earlier years visit ORCID
Open access indicates that an output is open access.
| Year | Output |
|---|---|
| 2025 |
Open access
1
1
|
| 2025 |
Open access
2
|
| 2025 |
Open access
|
| 2024 |
Open access
17
17
|
| 2024 |
Open access
13
13
2
|
| 2024 |
Open access
3
2
|
| 2024 |
Open access
2
|
| 2024 |
Open access
8
7
1
|
| 2024 |
65
60
116
|
| 2023 |
Open access
44
40
279
|
| 2023 |
Open access
9
8
19
|
| 2023 |
Open access
2
2
2
|
| 2023 |
Open access
12
12
4
|
| 2022 |
54
51
10
|
| 2022 |
Open access
33
30
70
|
| 2022 |
Open access
27
28
1
|
| 2021 |
Open access
41
40
120
|
| 2021 |
Goodall, GJ & Wickramasinghe, VO 2021, 'RNA in cancer', Nature Reviews Cancer, vol. 21, pp. 22-36.
Open access
834
817
|
| 2021 |
Open access
16
17
|
| 2021 |
Open access
9
7
|
| 2021 |
Open access
22
21
8
|
| 2021 |
Open access
13
13
2
|
| 2020 |
Open access
6
7
1
|
| 2020 |
Open access
9
9
|
| 2020 |
Open access
13
10
9
|
| 2020 |
Open access
1555
1412
|
| 2019 |
Open access
28
27
5
|
| 2019 |
Open access
16
16
1
|
| 2019 |
Open access
8
7
5
|
| 2019 |
15
17
1
|
| 2019 |
Open access
121
115
|
| 2018 |
Open access
123
124
|
| 2018 |
Open access
20
|
| 2018 |
Open access
74
69
28
|
| 2018 |
Open access
30
28
2
|
| 2018 |
Open access
23
20
1
|
| 2018 |
Open access
87
86
15
|
| 2018 |
Open access
44
40
|
| 2017 |
Open access
101
101
57
|
| 2017 |
48
46
|
| 2017 |
Open access
95
94
11
|
| 2017 |
Open access
62
58
7
|
| 2016 |
Open access
598
566
32
|
| 2015 |
54
53
18
|
| 2015 |
Open access
50
50
1
|
| 2015 |
Open access
1787
1727
21
|
| 2015 |
Open access
36
33
|
| 2015 |
Open access
30
28
|
| 2015 |
Open access
46
47
|
| 2015 |
Open access
36
34
2
|
| 2015 |
Open access
64
60
5
|
| 2014 |
Open access
56
58
|
| 2014 |
Open access
124
121
|
| 2014 |
55
53
|
| 2014 |
Open access
61
57
|
| 2014 |
Open access
26
25
|
| 2014 |
69
59
|
| 2014 |
33
32
|
| 2014 |
Open access
22
19
|
| 2013 |
Open access
21
19
|
| 2013 |
Open access
172
156
|
| 2013 |
Open access
153
142
|
| 2013 |
Open access
150
140
|
| 2013 |
Open access
105
102
|
| 2012 |
Open access
143
140
|
| 2012 |
93
85
|
| 2012 |
401
376
|
| 2011 |
Open access
71
68
|
| 2011 |
Open access
508
477
|
| 2011 |
Open access
131
124
|
| 2011 |
Open access
479
448
|
| 2011 |
Open access
184
169
|
| 2010 |
102
99
|
| 2010 |
Open access
77
66
|
| 2010 |
Open access
123
120
|
| 2010 |
Open access
88
76
|
| 2009 |
107
96
|
| 2009 |
32
30
|
| 2009 |
450
428
|
| 2009 |
53
51
|
| 2008 |
Open access
952
900
|
| 2008 |
3444
3242
|
| 2008 |
Open access
447
411
|
| 2008 |
Open access
76
72
|
External engagement & recognition
| Organisation | Country |
|---|---|
| Australian National University | AUSTRALIA |
| Bar-Ilan University | ISRAEL |
| Baylor College of Medicine | UNITED STATES |
| Canberra Hospital | AUSTRALIA |
| Cancer Council of South Australia | AUSTRALIA |
| Central Queensland University | AUSTRALIA |
| Charles Sturt University | AUSTRALIA |
| Children's Cancer Institute Australia | AUSTRALIA |
| Childrens Hospital at Westmead | AUSTRALIA |
| Dali University | CHINA |
| Deakin University | AUSTRALIA |
| Flinders University | AUSTRALIA |
| Friedrich Miescher Institute for Biomedical Research | SWITZERLAND |
| Garvan Institute of Medical Research | AUSTRALIA |
| Ghent University | BELGIUM |
| Hanson Institute | AUSTRALIA |
| Harvard University | UNITED STATES |
| Hudson Institute of Medical Research | AUSTRALIA |
| Institute of Medical and Veterinary Science | AUSTRALIA |
| Istituto di Ricerche Farmacologiche Mario Negri | ITALY |
| Kanazawa University | JAPAN |
| Kumamoto University | JAPAN |
| Kunming University of Science and Technology | CHINA |
| Mahidol University | THAILAND |
| Memorial Sloan Kettering Cancer Centre | UNITED STATES |
| Monash University | AUSTRALIA |
| Monterrey Institute Of Technology And Higher Education | MEXICO |
| Mount Sinai Hospital | UNITED STATES |
| Nagasaki University | JAPAN |
| National University of Singapore | SINGAPORE |
| Peter MacCallum Cancer Centre | AUSTRALIA |
| QIMR Berghofer Medical Research Institut | AUSTRALIA |
| Queensland University of Technology | AUSTRALIA |
| Royal Brisbane and Women's Hospital | AUSTRALIA |
| Royal Children's Hospital | UNITED KINGDOM |
| SA Pathology | AUSTRALIA |
| Shanghai Jiao Tong University | CHINA |
| South Australian Health and Medical Institute | AUSTRALIA |
| St Vincent's Hospital | AUSTRALIA |
| St. Vincent's Institute of Medical Research | AUSTRALIA |
| Stanford University | UNITED STATES |
| Sun Yat-Sen University | CHINA |
| The Institut Pasteur | FRANCE |
| The Queen Elizabeth Hospital | AUSTRALIA |
| University Health Network | CANADA |
| University Libre Bruxelles | BELGIUM |
| University of Adelaide | AUSTRALIA |
| University of Arizona | UNITED STATES |
| University of Basel | SWITZERLAND |
| University of Bonn | GERMANY |
| University of British Columbia | CANADA |
| University of California | UNITED STATES |
| University of California San Diego | UNITED STATES |
| University of Canberra | AUSTRALIA |
| University of Laval | CANADA |
| University of Malaya | MALAYSIA |
| University of Melbourne | AUSTRALIA |
| University of New South Wales | AUSTRALIA |
| University of Newcastle | AUSTRALIA |
| University of North Carolina at Chapel Hill | UNITED STATES |
| University Of Oklahoma Norman | UNITED STATES |
| University of Pennsylvania | UNITED STATES |
| University of Queensland | AUSTRALIA |
| University of South Australia | AUSTRALIA |
| University of Surrey | UNITED KINGDOM |
| University of Sydney | AUSTRALIA |
| University of Texas | UNITED STATES |
| University of Texas MD Anderson Cancer Centre | UNITED STATES |
| University of Toronto | CANADA |
| Walter and Eliza Hall Institute of Medical Research | AUSTRALIA |
| Women's and Children's Hospital | AUSTRALIA |
External engagement & recognition
| Engagement/recognition | Year |
|---|---|
FellowAustralian Academy of Science |
2018 |
Julian Wells MedalLorne Genome Conference |
2018 |
Project GrantNational Health and Medical Research Council (NHMRC) |
2016 |
FellowAustralian Academy of Health and Medical Science |
2015 |
Teaching & student supervision
Supervisions from 2010 shown
| Thesis title | Student status |
|---|---|
| 110423 - Tackling Neuroblastoma using a multi-omics bioinformatics approach | Current |
| 111069 - Illuminating the function of alternative splicing in cancer using CRISPR-based screens | Current |
| A novel protein ZCCHC24 as a regulator of breast cancer cell plasticity and metastasis | Current |
| Alternative splicing networks and their impact on the development of aggressive prostate cancer | Current |
| Identification of Molecular Drivers of Neuroblastoma | Current |
| MicroRNAs involved in neuroblastoma | Current |
| Targeting oncogenic signalling with custom RNA drugs | Current |
| Transforming Growth Factor-ß (TGF-ß) responsive regulators of Epithelial-mesenchymal transition | Current |
| Understanding how the epigenetic field effect exerted by cancers upon their microenvironment promotes tumour progression | Current |
| Computational modelling for breast cancer prognosis in precision medicine | Completed |
| Developing network inference methods for cancer driver discovery | Completed |
| Elucidating coding region targets of microRNAs | Completed |
| MicroRNA "super-targeting" and the role of miR-200c in epithelial to mesenchymal transition and primary cilia dynamics | Completed |
| The role of RNA-binding proteins in epithelial-mesenchymal transition | Completed |